Charles River Laboratories International (CRL) Interest & Investment Income (2009 - 2026)

Charles River Laboratories International has reported Interest & Investment Income for 18 years, with the latest figure at $1.0 million in Q2 2026.

• On a quarterly basis, Interest & Investment Income fell 5.93% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $4.5 million, a 23.19% decrease from a year earlier, with the FY2025 full-year figure at $4.9 million, down 42.39% from the prior year.
• Interest & Investment Income was $1.0 million for Q2 2026 at Charles River Laboratories International, roughly flat from $1.0 million in the prior quarter.
• The five-year high for Interest & Investment Income was $3.0 million in Q2 2024, with the low at $122000.0 in Q3 2022.
• Average Interest & Investment Income over 5 years is $1.2 million, with a median of $1.2 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Interest & Investment Income surged 1025.41% in 2023, then sank 63.55% in 2025.
• Over 5 years, Interest & Investment Income stood at $343000.0 in 2022, then surged by 363.85% to $1.6 million in 2023, then grew by 15.34% to $1.8 million in 2024, then plunged by 44.58% to $1.0 million in 2025, then grew by 1.47% to $1.0 million in 2026.
• The last three Interest & Investment Income figures came in at $1.0 million (Q2 2026), $1.0 million (Q1 2026), and $1.0 million (Q4 2025), per Business Quant data.